Do children born after assisted reproductive technology (ART) have an increased risk of developing cancer than other children? Many studies published in recent years have provided contradictory evidence, but the largest research just published on [more]
In a viewpoint published on JAMA Oncology, experts from University of Texas MD Anderson Cancer Center, Houston, have raised the question whether it is always convenient to ask patient consent before publishing case reports. The [more]
A subset of patients with head and neck cancer (HNC) who regularly used aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) for more than 6 months showed longer disease-specific survival and overall survival than nonregular NSAID [more]
“Immune checkpoint inhibitor (ICI) treatments benefit some patients with metastatic cancers, but predictive biomarkers are needed”: starting from this premise, a group of researchers of the Memorial Sloan Kettering Cancer Center in New York led [more]
Following the third UN high-level summit on non-communicable diseases last September, and with preparations for the 2019 high-level summit on Universal Health Coverage gathering speed, the World Oncology Forum (WOF) is making the case for [more]
A huge gap in the Hellenic Organization for Health Care Services Provision reimbursement system (EOPPY) for cancer biomarkers is causing a lot of trouble for doctors and patients. At the moment the Ministry of health [more]
In the six months after a diagnosis of cancer, suicide risk increases significantly, up to 20% relative to the general population, according to a paper recently published on JAMA Psychiatry. To evaluate the impact of [more]
Are 6 months of adjuvant chemotherapy really necessary for a patient with a stage III colorectal cancer? The answer should be “yes”, at least according to a paper recently published on the New England Journal [more]
Recently, Allison and Honjo have been awarded with the Nobel prize for their findings leading to the new cancer treatment approaches known as immune checkpoint inhibitors (ICIs). Thanks to these discoveries in fact, the management of [more]
In patients with early cervical cancer, minimally invasive surgery is likely not the best option, according to two studies with “alarming data” appearing in the latest issue of the New England Journal of Medicine. “Minimally [more]
With the goal of “saving additional 250,000 Europeans every year”, EuropaColon decided to expand its activities to all digestive cancers: oesophageal, stomach, colon, rectum, pancreas and rare digestive cancers. Digestive Cancers Europe, as the new [more]
“Tobacco control efforts implemented since the 1960s will continue to reduce lung cancer rates well into the next half-century. Additional prevention and cessation efforts will be required to sustain and expand these gains to further [more]
After the European Medicines Agency (EMA) approves a new cancer drug, reimbursement decisions by each country’s health authorities can take up to one year, with wide variations between countries. according to a study just presented [more]